PPIs included on list of drugs to 'seriously consider deprescribing' | Inside sources say Apple pursued talks to buy medical clinics | American College of Gastroenterology awards 21 SCOPYs: Drs. Adewale Ajumobi, Jinendra Satiya among recipients | IBS-C drug Plecanatide effective in phase III trial

October 18, 2017

Today's Top Stories

1. Renewed interest in gastroparesis research brings cure into focus - 4 key notes

Full story

2. PPIs included on list of drugs to 'seriously consider deprescribing' Full story

3. Inside sources say Apple pursued talks to buy medical clinics Full story

4. Webinar: Device intensive procedures in the ASC: Key thoughts on reimbursement challenges and how federal regulations will affect the ASC revenue cycle. To learn more and register, click here.

5. Medical societies call on Congress to provide MACRA flexibility - 4 insights Full story

6. American College of Gastroenterology awards 21 SCOPYs: Drs. Adewale Ajumobi, Jinendra Satiya among recipients Full story

7. Webinar: A new way to look at your pharmacy's resources: how remote models can help you redeploy your onsite teams. Register today!

8. IBS-C drug Plecanatide effective in phase III trial - 4 insights Full story

9. GI leader to know: Dr. Richard Cline of Blount Gastroenterology Associates Full story

10. Colon Cancer Alliance CEO calls executive order ending subsidies 'unacceptable gamble' Full story

11. Ohio hospital closed indefinitely after fire Full story

Companies to Know

Thank you to our sponsors

Cardinal Health
Paradigm Spine
Pacira Pharmaceuticals

McKesson Medical Surgical
National Medical Billing Services

Medline Industries, Inc.

CollectRX

North American Partners in Anesthesia
Zimmer Biomet

Regent Surgical Health

Modernizing Medicine
ECG Management Consultants
Surgical Information Systems
Smith & Nephew
Surgical Care Affiliates
AAAHC
Healthcare Appraisers, Inc.
ASCOA
Olympus America
Anesthesia Business Consultants